Skip to main content
Signal8

Lazar David E.

SEC insider (Form 3/4/5 filer). CIK 0001932843. Chief Executive Officer at Aterian, Inc. (ATER) and 8 other issuers. 38 reported Form 4/5 transactions since Sep 2024; latest on Sep 25, 2026. Located in PANAMA CITY.

Companies Lazar David E. has filed insider reports for

  • Aterian, Inc. (ATER): Director, Officer, 10% Owner, Chief Executive Officer
  • Quantum Cyber N.V. (QUCY): Director, Officer, 10% Owner, Chief Executive Officer
  • Sow Good Inc. (SOWG): Director
  • Indaptus Therapeutics, Inc. (INDP): Director
  • NovaBay Pharmaceuticals, Inc. (NBY): 10% Owner
  • KALA BIO, Inc. (KALA): Director, Officer, Chief Executive Officer
  • Cyclacel Pharmaceuticals, Inc. (CYCC): Officer, 10% Owner, Interim CEO
  • LQR House Inc. (LQR): Director, Officer, President
  • MINIM, INC. (MINM): Director, 10% Owner
Lazar David E. profile photo

Lazar David E.

CIK: 0001932843

Transaction Breakdown

Open Market Buys (P)1 (2.6%)

High conviction signal

Open Market Sales (S)11 (28.9%)

Position reduction

Option Exercises (M)4 (10.5%)

Derivative conversions

Awards (A)15 (39.5%)

Compensation grants

Other (G, F, J, C, D, …)7 (18.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (9)

Aterian, Inc. logo
ATER

Aterian, Inc.

DirectorOfficer10% Owner
Quantum Cyber N.V. logo
QUCY

Quantum Cyber N.V.

DirectorOfficer10% Owner
Sow Good Inc. logo
SOWG

Sow Good Inc.

Director
Indaptus Therapeutics, Inc. logo
INDP

Indaptus Therapeutics, Inc.

Director
NovaBay Pharmaceuticals, Inc. logo
NBY

NovaBay Pharmaceuticals, Inc.

10% Owner
KALA BIO, Inc. logo
KALA

KALA BIO, Inc.

DirectorOfficer
Cyclacel Pharmaceuticals, Inc. logo
CYCC

Cyclacel Pharmaceuticals, Inc.

Officer10% Owner
LQR House Inc. logo
LQR

LQR House Inc.

DirectorOfficer
MINIM, INC. logo
MINM

MINIM, INC.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (38 total)

  • Aterian, Inc. logo
    ATER

    Aterian, Inc.

    Sep 25, 2026
    Sale

    Series AA Convertible Non-Redeemable Preferred Stock

    Direct
    706.1K shares at avg. $0.38-
  • Aterian, Inc. logo
    ATER

    Aterian, Inc.

    Sep 25, 2026
    Sale

    Series AAA Convertible Non-Redeemable Preferred Stock

    Direct
    1.8M shares at avg. $6.70-
  • Aterian, Inc. logo
    ATER

    Aterian, Inc.

    Sep 24, 2026
    Conversion
    Direct
    1.3M shares-
  • Quantum Cyber N.V. logo
    QUCY

    Quantum Cyber N.V.

    Aug 5, 2026
    Conversion
    Direct
    9M shares at avg. $9.00$81.0M
  • Quantum Cyber N.V. logo
    QUCY

    Quantum Cyber N.V.

    Aug 5, 2026
    Conversion
    Direct
    9M shares at avg. $9.00$81.0M
  • Quantum Cyber N.V. logo
    QUCY

    Quantum Cyber N.V.

    Aug 5, 2026
    Conversion
    Direct
    28.1M shares at avg. $225.00$6.3B
  • Quantum Cyber N.V. logo
    QUCY

    Quantum Cyber N.V.

    Aug 5, 2026
    Conversion
    Direct
    9M shares at avg. $9.00$81.0M
  • Aterian, Inc. logo
    ATER

    Aterian, Inc.

    Aug 4, 2026
    Conversion
    Direct
    875K shares at avg. $2.00$1.8M
  • Aterian, Inc. logo
    ATER

    Aterian, Inc.

    Jul 17, 2026
    Award

    Series AAA Convertible Non-Redeemable Preferred Stock

    Direct
    1.8M shares at avg. $2.00-
  • Aterian, Inc. logo
    ATER

    Aterian, Inc.

    Apr 27, 2026
    Award

    Series AA Convertible Non-Redeemable Preferred Stock

    Direct
    1.8M shares-

1-10 of 38